Form 4 holding
Director
Taysha Gene Therapies, Inc.
- Security class
- Common Stock
- Shares / value
- 127,178
- Estimated value
- $568,485
- Report date
- 01 Jun 2026
- Price
- $4.47
- Ownership
- Direct
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|